(Q24308743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Frédéric Becq

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Caroline Norez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martina Wilke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marcel Bijvelds

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Huub Jorna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Patricia Melin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hugo DeJonge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

10 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

2081-2086

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Phosphorylation-regulated CI− channel in CHO cells stably expressing the cystic fibrosis gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Quality control in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Roles of N-linked glycans in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Conformation-independent binding of monoglucosylated ribonuclease B to calnexin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Targeting glycosylation as a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

cAMP- and Ca2+-independent activation of cystic fibrosis transmembrane conductance regulator channels by phenylimidazothiazole drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Animal models of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Traffic jams II: an update of diseases of intracellular transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

7 January 2021

Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

7 January 2021

A cystic fibrosis tracheal gland cell line, CF-KM4. Correction by adenovirus-mediated CFTR gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

7 January 2021

Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.010

7 January 2021

10.1016/J.FEBSLET.2006.03.010

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3414280

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16546175%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3414280

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3414280